Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.

PurposeTo describe the use of intracameral bevacizumab (ICB) Avastin in neovascular glaucoma (NVG) as the first maneuver before pan retinal photocoagulation and/or filtering surgery.MethodsBetween June 2006 and May 2007, 6 consecutive patients with NVG underwent intracameral injection of bevacizumab